AnalystsSuraj KaliaSuraj Kalia's Stock Forecasts
AnalystsSuraj Kalia
Analyst Ranking
Top 33%
#1602 out of 4995 analysts
Average Return
+1.26%
Win Rate
46%35 out of 76
Risk vs Reward
Poor
Good
Suraj Kalia's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Transmedics Group IncTMDX | +151.82% | $37.28 | $93.88 | 2022-08-02 - 2023-08-01 | Buy |
Tactile Systems Technology IncTCMD | +149.02% | $9.16 | $22.81 | 2022-08-02 - 2023-08-01 | Buy |
Transmedics Group IncTMDX | +146.14% | $13.61 | $33.50 | 2020-04-07 - 2021-04-07 | Buy |
Irhythm Technologies IncIRTC | +123.29% | $73.88 | $164.97 | 2024-08-02 - 2025-08-01 | Buy |
Irhythm Technologies IncIRTC | +81.85% | $93.00 | $169.12 | 2025-01-08 - 2025-08-22 | Buy |
Suraj Kalia Analyst Color
Get additional color on Suraj Kalia's coverage of popular stocks
Suraj Kalia's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pulse Biosciences IncPLSE | 1 | Buy | $22.00 | +29.03% | Initiates Coverage On | 2 months ago |
Transmedics Group IncTMDX | 11 | Buy | $150.00 | +25.16% | Maintains | 2 months ago |
Atricure IncATRC | 6 | Buy | $45.00 | +19.49% | Maintains | 6 months ago |
Varex Imaging CorpVREX | 5 | Buy | $23.00 | +97.93% | Maintains | 7 months ago |
Irhythm Technologies IncIRTC | 5 | Buy | $120.00 | -29.04% | Maintains | 8 months ago |
Artivion IncAORT | 3 | Buy | $32.00 | -28.62% | Maintains | 10 months ago |
Lemaitre Vascular IncLMAT | 2 | Buy | $93.00 | -7.31% | Reiterates | 10 months ago |
Abbott LaboratoriesABT | 1 | Buy | $130.00 | -1.95% | Initiates Coverage On | a year ago |
Trisalus Life Sciences IncTLSI | 1 | Buy | $10.00 | +98.02% | Initiates Coverage On | a year ago |
Edwards Lifesciences CorpEW | 5 | Buy | $90.00 | +9.98% | Maintains | a year ago |
Nyxoah SaNYXH | 4 | Buy | $13.00 | N/A | Maintains | a year ago |
Integer Holdings CorpITGR | 1 | Buy | $135.00 | N/A | Initiates Coverage On | a year ago |
Resmed IncRMD | 5 | Buy | $200.00 | N/A | Maintains | a year ago |
Silk Road Medical IncSILK | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Tactile Systems Technology IncTCMD | 4 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Nevro CorpNVRO | 2 | Buy | $35.00 | N/A | Maintains | 2 years ago |
Beyond Air IncXAIR | 1 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Ge Healthcare Technologies IncGEHC | 1 | Buy | $97.00 | N/A | Initiates Coverage On | 2 years ago |
Shockwave Medical IncSWAV | 4 | Sell | $165.00 | N/A | Reiterates | 2 years ago |
Viewray IncVRAYQ | 2 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
Biolife Solutions IncBLFS | 2 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Butterfly Network IncBFLY | 1 | Buy | $4.50 | N/A | Initiates Coverage On | 3 years ago |
Titan Medical IncTMDIF | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Humacyte IncHUMA | 1 | Buy | $16.00 | N/A | Initiates Coverage On | 4 years ago |
Perspective Therapeutics IncCATX | 1 | Buy | $1.00 | N/A | Initiates Coverage On | 5 years ago |
Venus Concept IncVERO | 1 | Buy | $660.00 | N/A | Upgrades | 5 years ago |
Inspire Medical Systems IncINSP | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Nano X Imaging LtdNNOX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Baxter International IncBAX | 1 | Buy | $100.00 | N/A | Initiates Coverage On | 5 years ago |
Intersect Ent IncXENT | 2 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Cardiovascular Systems IncCSII | 1 | Buy | $47.00 | N/A | Initiates Coverage On | 5 years ago |
Intuitive Surgical IncISRG | 1 | Sell | $121.67 | N/A | Downgrades | 5 years ago |
Apollo Endosurgery IncAPEN | 2 | Sell | $3.00 | N/A | Downgrades | 7 years ago |
Viveve Medical IncVIVE | 1 | Buy | $8,000.00 | N/A | Initiates Coverage On | 8 years ago |
Dexcom IncDXCM | 3 | Buy | $21.25 | N/A | Initiates Coverage On | 8 years ago |
Spectranetics CorpSPNC | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Nxstage Medical IncNXTM | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.